# MBD2

## Overview
MBD2 (methyl-CpG binding domain protein 2) is a gene that encodes a protein involved in the regulation of gene expression through its role in chromatin remodeling and transcriptional repression. The protein, also known as methyl-CpG binding domain protein 2, is a member of the methyl-CpG binding domain (MBD) protein family, which is characterized by its ability to bind specifically to methylated cytosines in DNA. This binding is crucial for the recruitment of the Nucleosome Remodeling and Deacetylase (NuRD) complex, facilitating chromatin compaction and gene silencing (Leighton2020The; Scarsdale2011Solution). MBD2 is expressed in various isoforms, each with distinct roles in cellular processes, including immune system function and fetal hemoglobin regulation (Yu2019Disruption; Wood2016Emerging). The gene's dysregulation is implicated in several diseases, such as cancer and autoimmune disorders, highlighting its significance as a potential therapeutic target (Chen2011Decreased; Mahmood2019DNA).

## Structure
MBD2 (methyl-CpG binding domain protein 2) is characterized by several structural features that contribute to its function in gene regulation. The protein contains a methyl-CpG binding domain (MBD) that specifically recognizes and binds to methylated cytosines in DNA, playing a crucial role in transcriptional repression (Schmolka2023Dissecting; Scarsdale2011Solution). The MBD domain is well-structured and stable, with its binding affinity influenced by the DNA sequence surrounding the methylated CpG site (Scarsdale2011Solution).

MBD2 also includes a coiled-coil domain, which is involved in protein-protein interactions, particularly with the GATA zinc finger domain containing 2A (GATAD2A/p66α) within the NuRD complex (Walavalkar2013Unique). This interaction is crucial for the formation of the NuRD complex, which is involved in chromatin remodeling and gene silencing (Leighton2020The).

The protein has an intrinsically disordered region (IDR) between the MBD and coiled-coil domains, which enhances DNA binding by reducing the off-rate and increasing affinity (Williams2015A). MBD2 exists in multiple isoforms, such as MBD2a, MBD2b, and MBD2t, which differ in their N-terminal and C-terminal regions, affecting their function and interaction with the NuRD complex (Schmolka2023Dissecting; Leighton2020The). These structural features and isoforms allow MBD2 to play a versatile role in gene regulation and chromatin dynamics.

## Function
MBD2 (methyl-CpG binding domain protein 2) is a key player in transcriptional regulation through its interaction with the nucleosome remodeling and histone deacetylation (NuRD) complex. It binds to methylated CpG-rich DNA, inducing DNA bending, which contributes to chromatin compaction and gene silencing (Leighton2020The). MBD2 is highly conserved and ubiquitously expressed, with its role in healthy human cells involving chromatin remodeling and gene expression modulation (Wood2016Emerging). 

MBD2 has three isoforms: MBD2a, MBD2b, and MBD2c. MBD2a and MBD2b differ in the inclusion of a GR-rich N-terminal domain in MBD2a, which affects interactions with DNA and the NuRD complex. MBD2c is a truncated isoform expressed in testes and embryonic stem cells, lacking the C-terminal TRD and not interacting with the NuRD complex (Wood2016Emerging). 

In the immune system, MBD2 is involved in the differentiation and function of T cell populations, influencing the proliferation and maturation of CD4+ and CD8+ T cells (Wood2016Emerging). MBD2 also plays a role in the regulation of fetal hemoglobin expression, where its disruption leads to increased expression of γ-globin in adult erythroid cells (Yu2019Disruption).

## Clinical Significance
Alterations in the expression of the MBD2 gene have significant clinical implications, particularly in cancer and autoimmune diseases. In various cancers, MBD2 is involved in the silencing of tumor suppressor genes, contributing to tumor progression. For instance, in breast cancer, MBD2 knockdown activates tumor suppressor genes like DAPK1 and KLK10, inhibiting cancer cell growth (Mahmood2019DNA; Gigek2015Methyl‐CpG‐Binding). In colon cancer, MBD2 binds to hypermethylated promoters of tumor suppressor genes such as p14 and p16, silencing them and promoting tumorigenesis (Gigek2015Methyl‐CpG‐Binding). In prostate cancer, MBD2 represses key tumor suppressor genes, impacting cancer development (Mahmood2019DNA).

MBD2 also plays a role in immune regulation. Its expression is linked to autoimmune diseases like systemic lupus erythematosus and psoriasis, where increased MBD2 levels are observed (Wood2016Emerging). In primary immune thrombocytopenia (ITP), decreased MBD2 expression is associated with genome-wide hypomethylation, potentially contributing to the disease's pathogenesis (Chen2011Decreased). These findings highlight MBD2's role in both cancer and immune-related conditions, making it a potential target for therapeutic interventions. However, caution is advised in targeting MBD2 to avoid unintended consequences (Mahmood2019DNA).

## Interactions
MBD2 (methyl-CpG binding domain protein 2) is a key component of the Nucleosome Remodeling and Deacetylase (NuRD) complex, where it interacts with various proteins to mediate chromatin remodeling and transcriptional repression. MBD2 binds to methylated CpG sequences and recruits the NuRD complex, which includes components such as CHD3/4, HDAC1/2, and GATAD2A/B (Yu2019Disruption). The interaction between MBD2 and GATAD2A is facilitated by a C-terminal coiled-coil motif, which is crucial for the recruitment of CHD4 to the NuRD complex (Yu2019Disruption).

MBD2 also interacts with p66α (GATAD2A), which is essential for MBD2-mediated DNA methylation-dependent gene silencing. This interaction involves a coiled-coil domain that recruits CHD4/Mi2β to the NuRD complex (Walavalkar2013Unique). The binding affinity between MBD2 and p66α is influenced by the helicity and electrostatic potential of the MBD2 domain (Walavalkar2013Unique).

MBD2 forms both homo- and hetero-interactions with MeCP2, another member of the MBD protein family. These interactions occur even in the absence of DNA and involve specific domains within the proteins (Becker2013Direct). The N-terminal domain of MBD2 is crucial for these interactions, suggesting a role in crosslinking chromatin fibers (Becker2013Direct).


## References


[1. (Williams2015A) David C. Williams, Megha Desai, and Gordon D. Ginder. A fuzzy dna binding region in mbd2 recruits the histone deacetylase core complex of nurd and modifies kinetics of dna binding. Biophysical Journal, 108(2):388a, January 2015. URL: http://dx.doi.org/10.1016/J.BPJ.2014.11.2125, doi:10.1016/j.bpj.2014.11.2125. This article has 1 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/J.BPJ.2014.11.2125)

[2. (Scarsdale2011Solution) J. Neel Scarsdale, Heather D. Webb, Gordon D. Ginder, and David C. Williams. Solution structure and dynamic analysis of chicken mbd2 methyl binding domain bound to a target-methylated dna sequence. Nucleic Acids Research, 39(15):6741–6752, April 2011. URL: http://dx.doi.org/10.1093/nar/gkr262, doi:10.1093/nar/gkr262. This article has 83 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkr262)

[3. (Mahmood2019DNA) Niaz Mahmood and Shafaat A. Rabbani. Dna methylation readers and cancer: mechanistic and therapeutic applications. Frontiers in Oncology, June 2019. URL: http://dx.doi.org/10.3389/fonc.2019.00489, doi:10.3389/fonc.2019.00489. This article has 91 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2019.00489)

[4. (Walavalkar2013Unique) Ninad M. Walavalkar, Nathaniel Gordon, and David C. Williams. Unique features of the anti-parallel, heterodimeric coiled-coil interaction between methyl-cytosine binding domain 2 (mbd2) homologues and gata zinc finger domain containing 2a (gatad2a/p66α). Journal of Biological Chemistry, 288(5):3419–3427, February 2013. URL: http://dx.doi.org/10.1074/jbc.M112.431346, doi:10.1074/jbc.m112.431346. This article has 46 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.M112.431346)

[5. (Yu2019Disruption) Xiaofei Yu, Alexander Azzo, Stephanie M. Bilinovich, Xia Li, Mikhail Dozmorov, Ryo Kurita, Yukio Nakamura, David C. Williams, and Gordon D. Ginder. Disruption of the mbd2-nurd complex but not mbd3-nurd induces high level hbf expression in human adult erythroid cells. Haematologica, 104(12):2361–2371, April 2019. URL: http://dx.doi.org/10.3324/haematol.2018.210963, doi:10.3324/haematol.2018.210963. This article has 43 citations.](https://doi.org/10.3324/haematol.2018.210963)

[6. (Becker2013Direct) Annette Becker, Lena Allmann, Maria Hofstätter, Valentina Casà, Patrick Weber, Anne Lehmkuhl, Henry D. Herce, and M. Cristina Cardoso. Direct homo- and hetero-interactions of mecp2 and mbd2. PLoS ONE, 8(1):e53730, January 2013. URL: http://dx.doi.org/10.1371/journal.pone.0053730, doi:10.1371/journal.pone.0053730. This article has 28 citations and is from a peer-reviewed journal.](https://doi.org/10.1371/journal.pone.0053730)

[7. (Schmolka2023Dissecting) Nina Schmolka, Ino D. Karemaker, Richard Cardoso da Silva, Davide C. Recchia, Vincent Spegg, Jahnavi Bhaskaran, Michael Teske, Nathalie P. de Wagenaar, Matthias Altmeyer, and Tuncay Baubec. Dissecting the roles of mbd2 isoforms and domains in regulating nurd complex function during cellular differentiation. Nature Communications, June 2023. URL: http://dx.doi.org/10.1038/s41467-023-39551-w, doi:10.1038/s41467-023-39551-w. This article has 0 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-023-39551-w)

[8. (Wood2016Emerging) Kathleen H. Wood and Zhaolan Zhou. Emerging molecular and biological functions of mbd2, a reader of dna methylation. Frontiers in Genetics, May 2016. URL: http://dx.doi.org/10.3389/fgene.2016.00093, doi:10.3389/fgene.2016.00093. This article has 52 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fgene.2016.00093)

[9. (Gigek2015Methyl‐CpG‐Binding) Carolina Oliveira Gigek, Elizabeth Suchi Chen, and Marilia Arruda Cardoso Smith. Methyl‐cpg‐binding protein (mbd) family: epigenomic read‐outs functions and roles in tumorigenesis and psychiatric diseases. Journal of Cellular Biochemistry, 117(1):29–38, November 2015. URL: http://dx.doi.org/10.1002/jcb.25281, doi:10.1002/jcb.25281. This article has 29 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/jcb.25281)

[10. (Leighton2020The) Gage Leighton and David C. Williams. The methyl-cpg–binding domain 2 and 3 proteins and formation of the nucleosome remodeling and deacetylase complex. Journal of Molecular Biology, 432(6):1624–1639, March 2020. URL: http://dx.doi.org/10.1016/j.jmb.2019.10.007, doi:10.1016/j.jmb.2019.10.007. This article has 27 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jmb.2019.10.007)

[11. (Chen2011Decreased) Zhen-ping Chen, Dong-sheng Gu, Ze-ping Zhou, Xiao-li Chen, Zhen-xing Guo, Wei-ting Du, Jing Ge, Qian Ren, and Ren-chi Yang. Decreased expression of mbd2 and mbd4 gene and genomic-wide hypomethylation in patients with primary immune thrombocytopenia. Human Immunology, 72(6):486–491, June 2011. URL: http://dx.doi.org/10.1016/j.humimm.2011.02.006, doi:10.1016/j.humimm.2011.02.006. This article has 15 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.humimm.2011.02.006)